| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.3B | $9.6B | $8.8B | $8.1B | $8.4B | $2.2B | $2.2B | $2.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.4B | $3.3B | $2.9B | $2.6B | $2.6B | $2.4B | $2.6B | $2.5B |
| Operating Income | $1.8B | $1.5B | $1.0B | $0.5B | $0.5B | $-0.0B | $-1.1B | $0.0B |
| Net Income | $0.2B | $-0.0B | $-0.6B | $-0.2B | $-0.9B | $-0.6B | $-1.8B | $-4.1B |
| EPS (Basic) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | — | $-5.08 | $-0.98 |
| EPS (Diluted) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | — | $-5.08 | $-0.98 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $26.4B | $26.5B | $27.4B | $25.7B | $29.2B | $31.2B | $33.9B | $32.5B |
| Current Assets | $6.2B | $5.8B | $5.6B | $4.2B | $5.6B | $5.3B | $7.0B | $4.2B |
| Cash & Equivalents | $1.3B | $1.2B | $0.9B | $0.6B | $0.6B | $0.6B | $3.2B | $0.7B |
| Total Liabilities | $26.0B | $26.8B | $27.4B | $25.4B | $29.2B | $30.6B | $32.7B | $29.7B |
| Current Liabilities | $4.2B | $6.8B | $4.3B | $3.9B | $5.2B | $4.9B | $6.2B | $3.8B |
| Stockholders' Equity | $-0.6B | $-1.3B | $-1.0B | $-0.7B | $-0.1B | $0.5B | $1.1B | $2.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.4B | $1.6B | $1.0B | $-0.7B | $1.4B | $0.4B | $0.2B | $0.3B |
| Investing Cash Flow | $-0.6B | $-0.5B | $-2.1B | $-0.3B | $0.4B | $-0.3B | $-0.4B | $-0.2B |
| Capital Expenditures | $0.4B | $0.3B | $0.2B | $0.2B | $0.3B | $0.3B | $0.3B | $0.2B |
| Financing Cash Flow | $-0.7B | $-0.9B | $1.5B | $-0.5B | $-1.5B | $-2.3B | $1.4B | $-1.4B |